SlideShare ist ein Scribd-Unternehmen logo
1 von 12
Downloaden Sie, um offline zu lesen
REGIONAL COMMITTEE                           Provisional Agenda item 10.2


Fifty-fifth Session                          SEA/RC55/7
11-13 September 2002

                                             25 July 2002




                  PREVENTION AND CONTROL OF DENGUE,
                 JAPANESE ENCEPHALITIS AND KALA-AZAR
                            IN SEA REGION
DENGUE FEVER
CONTENTS


                                                                                                                            Page



1. THE SITUATION.................................................................................................................. 1


2. PREVENTION AND CONTROL.......................................................................................... 3

     2.1      Regional Strategy for Prevention and Control of DF/DHF ........................................ 3
     2.2      Strategy for Prevention and Control of Kala-azar ..................................................... 5
     2.3      Strategy for Prevention and Control of Japanese Encephalitis ................................ 6
DENGUE FEVER
1.   THE SITUATION

Dengue fever is an acute febrile viral disease caused by flaviviruses. There are four serotypes
1, 2, 3 and 4. The re-infections of these serotypes are responsible for dengue haemorrhagic
fever (DHF) and the virus is transmitted to man by the bite of infective mosquitoes, mainly
Aedes aegypti. This disease is now endemic in most of the tropical countries.

       Dengue fever (DF), with its severe manifestations, such as dengue haemorrhagic fever
(DHF) and dengue shock syndrome (DSS), has emerged as a major public health problem of
international concern. It is a leading cause of childhood mortality in several Asian countries.
Fifty two per cent of the population at risk of DF/DHF lives in the WHO South-East Asia Region
(Figure 1). The geographical distribution has greatly expanded over the last 30 years because




                           Figure 1. Population at risk of DF/DHF, 2001


                                                                          Population
                                                                      at risk elsewhere
                                                                          (1.2 billion)



                                       52%             48%




          Population at risk in
             SEA Region
             (1.3 billion)




of increased potential for the breeding of Aedes aegypti.

      Seven countries of the Region (Bangladesh, India, Indonesia, Maldives, Myanmar,
Sri Lanka and Thailand) regularly report incidences of DF/DHF every year. Indonesia, Myanmar
and Thailand fall in the tropical monsoon and equatorial climatic zone. The annual rainfall
received by this region is less than 150 cm. There is widespread distribution of Aedes aegypti
mosquito in both urban and rural areas. The transmission period is extended and DHF
epidemics occur in 3-5 year cycles, associated with high morbidity in children. Bhutan and
Nepal, being high altitude countries, have not reported any case of DF/DHF. DPR Korea, being
a country with a temperate climate, has no report of indigenous transmission of DF/DHF.

     The trend of reported cases of DF/DHF and deaths in the Region for the period 1985-
2000 is shown in Figure 2. The total reported cases ranged from 46 458 in 1986 to 218 859
in 1998. During the epidemic years, the number of cases generally exceeds 100 000.
Similarly, reported deaths due to DHF ranged from 2 339 in 1987 to 471 in 1999. The
SEA/RC55/7
Page 2


number of deaths due to DHF continues to be high (>1 000) in most of the years. The case-
fatality rate, which fluctuated between 2 and 2.5 per cent up to 1990, has shown a downward
trend; during 1997-98 it was stable and ranged between 1 and 2 per cent. Following the largest
number of cases (218 859) reported in 1998, the number of reported cases declined markedly
to 55 405 in 1999 and 57 997 in 2000. The number of deaths declined from 2 075 in 1998 to
471 in 1999 and 542 in 2000. However, the case-fatality rate remained around one per cent in
1999-2000.

      Kala-azar or visceral leishmaniasis is a chronic and insidious disease caused by an
intracellular protozoan (Leishmania species). It is a rural disease and man is the main reservoir
of infection. Kala-azar is usually fatal if untreated. Sand fly (Phlebotomus argentipes), the vector
of kala-azar, breeds in mud shelters located in peri-domestic and animal shelters. Poverty is a
major determinant with the disease affecting the poor population who have little access to
health facilities and cannot afford treatment.

      Over 20% of the world's estimated 0.5 million annual cases occurred in the Indian states
of Bihar, West Bengal and Uttar Pradesh. During 1999, a total of 12 728 kala-azar cases (284
deaths) were reported from India, of which 90% cases were detected in Bihar alone. Nepal
reported kala-azar in areas along the border with Bihar and West Bengal, with 1 832 cases (28
deaths) in 1999. Bangladesh reported to 5 799 cases (24 deaths) in 1999.

      Kala-azar has been recognized as a cross-border health problem affecting Bangladesh,
India and Nepal. The incidence of kala-azar has a focus in the border districts, particularly on
the India-Nepal border. There are sporadic cases in the Bangladesh-India border, but in
Bangladesh the problem is more serious in areas far from the border.
SEA/RC55/7
                                                                                                                                                                             Page 3



                              Figure 2. Number of reported cases of DF/DHF and deaths
                                          in the SEA Region* (1985-2001**)


                             1000000                                                                                                                               2.5




                                                                                                                                                                            Case-fatalityrate (%)
       No. of cases/deaths




                              100000
                                                                                                                                                                   2

                               10000
                                                                                                                                                                   1.5

                                1000
                                                                                                                                                                   1
                                100

                                                                                                                                                                   0.5
                                 10


                                  1                                                                                                                                0




                                                                                                                                                           2001*
                                       1985

                                              1986

                                                     1987

                                                            1988

                                                                   1989

                                                                            1990

                                                                                   1991

                                                                                           1992

                                                                                                   1993

                                                                                                          1994

                                                                                                                 1995

                                                                                                                        1996

                                                                                                                               1997

                                                                                                                                      1998

                                                                                                                                             1999

                                                                                                                                                    2000
                                                                          Cases           Deaths          Case-fatality rate (%)




     * Bangladesh, India, Indonesia, Maldives, Myanmar, Sri Lanka and Thailand
     ** information upto September 2001




     Japanese encephalitis (JE) is a mosquito-borne zoonotic disease, caused by a group B
arbovirus (flavivirus). It mainly infects animals and birds; Man is an incidental host. The disease
usually occurs in areas under rice cultivation or with rich irrigation which favours the breeding of
Culex mosquitoes. The risk increases in the presence of a large number of animal reservoir
hosts such as pigs.

      JE is a major public health problem in Asia and is the most important cause of viral
encephalitis in the world. The most affected groups are children 1-15 years of age. JE affects
rice-producing areas and is characterized by cyclic epidemics every two years.

     JE is annually reported in four countries of the South-East Asia Region: India, Nepal, Sri
Lanka and Thailand. Sporadic cases have also been reported in Indonesia and Myanmar. India
and Nepal continue to report a high number of cases and deaths. The total number of cases
reported in the Region in 1999 was 6 514 with 1 121 deaths. During the same period, India
reported 3 428 cases with 680 deaths, Nepal 2 924 cases (434 deaths) while Sri Lanka and
Thailand reported only 102 and 60 cases respectively with 3 and 4 deaths.


2.    PREVENTION AND CONTROL


2.1 Regional Strategy for Prevention and Control of DF/DHF
SEA/RC55/7
Page 4


The countries of the South-East Asia Region developed a regional strategy for the control of
DF/DHF in 1995 which was revised in July 2001 with the following objectives:

     (1) To establish an effective disease and vector surveillance system based on reliable
         laboratory and health information systems;

     (2) To ensure early recognition and effective case management of DHF/DSS to prevent
         case mortality;

     (3) To undertake disease prevention and control through integrated vector management
         with community and intersectoral participation;

     (4) To undertake activities to achieve sustainable behavioural changes and partnerships;

     (5) To establish emergency response capacity to control outbreaks with appropriate
         medical services, vector control, communications and logistics, and

     (6) To strengthen regional and national capacities to undertake prevention and control of
         dengue and research related to epidemiology, disease and vector management and
         behavioural changes.

      Each country formulated its national control programme according to its priorities,
availability of infrastructure, resources, etc. Consequently, Thailand, Indonesia and Myanmar
established National Dengue Prevention and Control Programmes while Sri Lanka has
established a National Task Force for control of DF/DHF. India, Bangladesh and Maldives do
not have National Dengue Control Programmes, but control is integrated as part of vector-
borne disease control/malaria control organizations for emergency control of epidemics.

     Surveillance is crucial for priority setting, policy decision to reduce disease burden,
prediction and early detection of epidemics. All the countries of the Region have passive
surveillance systems, which do not help in predicting epidemics.

      Most of the dengue-endemic countries do not have the infrastructure to respond early and
effectively to control epidemics. Emphasis is always on fogging and larvicide application. There
has been an attempt to mobilize communities to undertake source reduction methods to
prevent transmission. In most of the cases, the community will rely almost exclusively on
government services to address the problem.

       Prompt diagnosis and standardized treatment is a key to successful case management
and thus reduce the case-fatality rate (CFR). In the SEA Region, clinicians and physicians in
Thailand have provided the leadership in this direction. Seminal studies on the pathogenesis
and pathophysiological changes in DHF patients were carried out in 1960 at Queen Sirikit’s
Institute of Child Health (WHO Collaborating Centre for Clinical Management of DF/DHF),
which resulted in the development of guidelines for clinical diagnosis and management of
severe cases to bring down CFR below 0.5%. These guidelines were adopted by WHO in 1975
and have also been incorporated into the IMCI (integrated management of childhood illness)
protocols of Indonesia, Vietnam and the Philippines.

     Based on the regional dengue control strategy of “selected, sustainable and integrated
control approach with community and intersectoral participation”, the countries of the Region
have developed various models of community-based control programme based upon source
reduction and have met with varying degree of success.
SEA/RC55/7
                                                                                          Page 5


2.2 Strategy for Prevention and Control of Kala-azar

Kala-azar control is based on improving access for target population to early case detection
and prompt treatment, vector control, health education as well as poverty alleviation measures.
Kala-azar diagnosis is costly and unreliable. An antigen-based K-39 test has become available
for rapid diagnosis. The anti-leishmaniasis drugs available for treatment are either unresponsive
(1st line-SAG) or 2nd line drugs are very expensive (amphotericin B). These drugs are toxic and
have to be administered parenterally for long periods. Increasing reports of resistant parasite
against these drugs have become a major issue in control efforts. An oral drug, miltefosine,
registered in India in early 2002, is under consideration for control programme in the India-
Nepal border districts. Low coverage and periodic interruptions frequently hamper the vector
control approach based on residual insecticide house spraying.

      Experience in the past has shown that the incidence of kala-azar could be kept at a very
low level for several years following large-scale interventions; the disease re-emerged when
interventions could not be sustained. Thus, from the economic point of view, eradication of
visceral leishmaniasis is not feasible, while control strategy would be too slow to contain the
spread of the disease.

Kala-azar elimination

Objective
Progressive reduction of human reservoir until the disease is no longer a public health problem.

Target

By 2012, the annual incidence of kala-azar at the village level will not exceed 1 per 1 000
population.

Time-frame

2003-2012

Strategy
     •   Early detection: Community awareness of the symptoms of kala-azar and when to
         seek treatment; surveillance and monitoring of drug resistance. Scaling up intervention
         targeting villages with a high burden of disease. Identification of individual cases using
         dipsticks followed by treatment with oral miltefosine. Use DOTS method to ensure
         compliance.
     •   Prompt treatment in the nearest health facility: Common protocol for diagnosis by
         using dipsticks, whenever possible, followed by treatment with oral miltefosine;
         community awareness on where to seek treatment and compliance.
     •   Multi-disease approach and multi-pronged interventions: Integrated care with other
         disease control such as malaria; promote wide use of insecticide-treated nets for
         community protection; environmental sanitation in and around the house; and
         integrated vector control. Application of two rounds of spraying with DDT for three
         consecutive years to quickly reduce vector density and curtail disease transmission.
SEA/RC55/7
Page 6


     •   Structured technical support: Institutional support for technical networks for capacity
         building, Kala-azar cell in NAMP.
     •   Operations research: Establishment of indicators for monitoring progress of
         elimination; behavioural study for promotion of community action.
     •   Coalition of stakeholders: Government, civil society, private sector, international
         organizations, research institutions and foundations.


Implementation
     •   Programme will be implemented as part of cross-border collaboration under ICP- II
         2002-2003 in four pilot districts, i.e. one each on the India-Nepal border and, similarly,
         one each on the Bangladesh-India border.
     •   Partnerships with industries to ensure the availability of cheap, reliable and
         sustainable supply of drugs, dipstick tests and insecticide for indoor residual spray.
     •   Development of a sensitive dipstick method for early detection of kala-azar.
     •   Production and marketing of affordable oral miltefosine as a drug of choice.
     •   Development of kala-azar vaccine, drug and diagnostic tools.


2.3 Strategy for Prevention and Control of Japanese Encephalitis

The strategy for prevention and control of JE includes three components: (1) Health education
and training; (2) Vector control; (3) Immunization, and (4) Epidemic preparedness and
response.


Health Education
     •   Simple Information on JE - cause, transmission and prevention of mosquito bites.
     •   Community action in reducing mosquito breeding places by filling pools, weekly
         drainage of accumulated water, lowering of water levels in rice fields etc.
     •   National guidelines for diagnosis, management and prevention of JE - for programme
         managers and health professionals.


Vector Control

Insecticide spraying is not considered as a major strategy. However, for the immediate
suppression of infective vectors, ULV or thermal fogging may be employed, which again is not
very cost-effective. Environmental measures are recommended.


Short-term measures
     •   Larviciding - impractical for widespread breeding habitats.

Long-term measures
SEA/RC55/7
                                                                                           Page 7


     •   Water management, specially in irrigated rice fields, e.g. periodic drying of fields.
     •   Selection of rice varieties with minimum water requirements.
     •   Use of larvivorous fish.
     •   Environment manipulations like reduction of drainage, filling and weeding.

Immunization
     •   of population at risk i.e. children
     •   of pigs

     Vaccination of humans is the only realistic tool to control JE. WHO recommends the use
of JE vaccine wherever it is affordable. Suggestions have been made to incorporate the
vaccine into EPI programmes in Asia.

Immunization of children

Since JE is annually reported in a few districts or pockets in the four JE endemic countries, e.g.
on either side of the border between Nepal and India, immunization of children aged 6 months
to 12 years is feasible. There are at least three vaccines being used: inactivated virus grown in
mouse brain, inactivated virus grown on primary hamster kidney cells and live attenuated virus
grown in primary hamster kidney cells (SA-14-14-2).

     Vaccines have been used in Japan, Republic of Korea, Taiwan, China, Thailand and
Nepal. A pilot study in Nepal found an eight-fold reduction compared with previous years and
up to 88% of JE cases detected were found among unvaccinated people. China and Japan
have successfully implemented vaccination with impressive results.

Pig vaccination

This is very costly, difficult and time-consuming. Pigs are normally slaughtered at 6-8 months of
age. Vaccination must begin when maternal antibodies have decreased but before the pig
becomes viraemic. Pig control has also been tried through segregation or slaughtering but this
is difficult and the economic losses are high. Therefore, human vaccination is the most feasible
and cost-effective tool for JE control.

Epidemic Preparedness and Response
     (1) Immediately notify government authorities by phone, fax or email.
     (2) A team of investigators consisting of clinicians, epidemiologists, entomologists etc.
         should be immediately sent to the affected site.
     (3) The team should be provided proper information on collection of specimens :
          – stool samples – for isolation of enterovirus
          – blood or serum on the first three days of the illness – for detection or isolation of
             virus
          – paired serum samples at an interval of at least 10 days – for antibody detection
SEA/RC55/7
Page 8


        – CSF – for virus isolation and antibody tests
        – in case of deaths – tissue samples of brain and liver.

    All samples must be stored in a cool place. For virus isolation, samples must be stored at
    temperatures below –20oC.

Weitere ähnliche Inhalte

Andere mochten auch

Poster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Poster on Psychosocial risk factors and musculoskeletal symptoms among nursesPoster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Poster on Psychosocial risk factors and musculoskeletal symptoms among nursesSiti Mastura
 
Case study- Dengue Fver
Case study- Dengue FverCase study- Dengue Fver
Case study- Dengue FverMj Hernandez
 
Nursing case study Pre eclampsia
Nursing case study Pre eclampsiaNursing case study Pre eclampsia
Nursing case study Pre eclampsiapinoy nurze
 
Nursing case study Appendectomy
Nursing case study AppendectomyNursing case study Appendectomy
Nursing case study Appendectomypinoy nurze
 
DENGUE FEVER
DENGUE FEVERDENGUE FEVER
DENGUE FEVERicsp
 

Andere mochten auch (8)

Poster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Poster on Psychosocial risk factors and musculoskeletal symptoms among nursesPoster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Poster on Psychosocial risk factors and musculoskeletal symptoms among nurses
 
Physio case study
Physio case studyPhysio case study
Physio case study
 
case study
case study case study
case study
 
Case study : dengue fever
Case study : dengue feverCase study : dengue fever
Case study : dengue fever
 
Case study- Dengue Fver
Case study- Dengue FverCase study- Dengue Fver
Case study- Dengue Fver
 
Nursing case study Pre eclampsia
Nursing case study Pre eclampsiaNursing case study Pre eclampsia
Nursing case study Pre eclampsia
 
Nursing case study Appendectomy
Nursing case study AppendectomyNursing case study Appendectomy
Nursing case study Appendectomy
 
DENGUE FEVER
DENGUE FEVERDENGUE FEVER
DENGUE FEVER
 

Ähnlich wie DENGUE FEVER

A spatial analysis: creating similarity domains for targeted research sites i...
A spatial analysis: creating similarity domains for targeted research sites i...A spatial analysis: creating similarity domains for targeted research sites i...
A spatial analysis: creating similarity domains for targeted research sites i...Joanna Hicks
 
1530 andries potgieter
1530 andries potgieter1530 andries potgieter
1530 andries potgieterJoanna Hicks
 
Livestock production and poverty alleviation in arid and semi-arid tropica...
Livestock production and poverty alleviation in arid and semi-arid tropica...Livestock production and poverty alleviation in arid and semi-arid tropica...
Livestock production and poverty alleviation in arid and semi-arid tropica...ILRI
 
Enhancing Resilience And Promoting Development In The Horn Of Africa
Enhancing Resilience And Promoting Development In The Horn Of AfricaEnhancing Resilience And Promoting Development In The Horn Of Africa
Enhancing Resilience And Promoting Development In The Horn Of Africaessp2
 
L verchot c loss luc tropical peatlands
L verchot c loss luc tropical peatlandsL verchot c loss luc tropical peatlands
L verchot c loss luc tropical peatlandstheREDDdesk
 
Slides Ed1
Slides Ed1Slides Ed1
Slides Ed1lizardyh
 
2 agriculture rural_sector
2 agriculture rural_sector2 agriculture rural_sector
2 agriculture rural_sectorsarfarazsharb
 
Enhancing resilience and promoting development in the horn of africa
Enhancing resilience and promoting development in the horn of africa Enhancing resilience and promoting development in the horn of africa
Enhancing resilience and promoting development in the horn of africa essp2
 

Ähnlich wie DENGUE FEVER (14)

A spatial analysis: creating similarity domains for targeted research sites i...
A spatial analysis: creating similarity domains for targeted research sites i...A spatial analysis: creating similarity domains for targeted research sites i...
A spatial analysis: creating similarity domains for targeted research sites i...
 
1530 andries potgieter
1530 andries potgieter1530 andries potgieter
1530 andries potgieter
 
Livestock production and poverty alleviation in arid and semi-arid tropica...
Livestock production and poverty alleviation in arid and semi-arid tropica...Livestock production and poverty alleviation in arid and semi-arid tropica...
Livestock production and poverty alleviation in arid and semi-arid tropica...
 
Enhancing Resilience And Promoting Development In The Horn Of Africa
Enhancing Resilience And Promoting Development In The Horn Of AfricaEnhancing Resilience And Promoting Development In The Horn Of Africa
Enhancing Resilience And Promoting Development In The Horn Of Africa
 
CPI
CPICPI
CPI
 
L verchot c loss luc tropical peatlands
L verchot c loss luc tropical peatlandsL verchot c loss luc tropical peatlands
L verchot c loss luc tropical peatlands
 
growth and_investment
growth and_investmentgrowth and_investment
growth and_investment
 
Slides Ed1
Slides Ed1Slides Ed1
Slides Ed1
 
Apre 1 t03
Apre 1 t03Apre 1 t03
Apre 1 t03
 
Business environment report
Business environment reportBusiness environment report
Business environment report
 
Save
Save Save
Save
 
Bur malaysia final
Bur malaysia finalBur malaysia final
Bur malaysia final
 
2 agriculture rural_sector
2 agriculture rural_sector2 agriculture rural_sector
2 agriculture rural_sector
 
Enhancing resilience and promoting development in the horn of africa
Enhancing resilience and promoting development in the horn of africa Enhancing resilience and promoting development in the horn of africa
Enhancing resilience and promoting development in the horn of africa
 

Mehr von Siti Mastura

PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSES
PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSESPSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSES
PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSESSiti Mastura
 
valuation of toxicological implications of inhalationexposure to kerosene fum...
valuation of toxicological implications of inhalationexposure to kerosene fum...valuation of toxicological implications of inhalationexposure to kerosene fum...
valuation of toxicological implications of inhalationexposure to kerosene fum...Siti Mastura
 
865_file_UNEP__20Emergency__20Preparedness_final
865_file_UNEP__20Emergency__20Preparedness_final865_file_UNEP__20Emergency__20Preparedness_final
865_file_UNEP__20Emergency__20Preparedness_finalSiti Mastura
 
Principles_Of_Hazard_Tree_Risk_Mgmnt
Principles_Of_Hazard_Tree_Risk_MgmntPrinciples_Of_Hazard_Tree_Risk_Mgmnt
Principles_Of_Hazard_Tree_Risk_MgmntSiti Mastura
 
fire fighting prevention
fire fighting preventionfire fighting prevention
fire fighting preventionSiti Mastura
 
PIHAK BERKUASA TEMPATAN
PIHAK BERKUASA TEMPATANPIHAK BERKUASA TEMPATAN
PIHAK BERKUASA TEMPATANSiti Mastura
 
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent VaporGuidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent VaporSiti Mastura
 
jurnal of occupational safety and health
jurnal of occupational safety and healthjurnal of occupational safety and health
jurnal of occupational safety and healthSiti Mastura
 
1-introductionbacteria
1-introductionbacteria1-introductionbacteria
1-introductionbacteriaSiti Mastura
 
Requirement and Technical Standard for Non Convention Cargo
Requirement and Technical Standard for Non Convention Cargo Requirement and Technical Standard for Non Convention Cargo
Requirement and Technical Standard for Non Convention Cargo Siti Mastura
 
fault tree analysis
fault tree analysisfault tree analysis
fault tree analysisSiti Mastura
 
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...Siti Mastura
 
japanese encephalitis
japanese encephalitisjapanese encephalitis
japanese encephalitisSiti Mastura
 
Communication for behavioral impact(COMBI)
Communication for behavioral impact(COMBI)Communication for behavioral impact(COMBI)
Communication for behavioral impact(COMBI)Siti Mastura
 
nominal group technique
nominal group techniquenominal group technique
nominal group techniqueSiti Mastura
 
157-national-medicines-policy-of-malaysia
157-national-medicines-policy-of-malaysia157-national-medicines-policy-of-malaysia
157-national-medicines-policy-of-malaysiaSiti Mastura
 

Mehr von Siti Mastura (20)

PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSES
PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSESPSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSES
PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSES
 
PenyakitKelamin
PenyakitKelaminPenyakitKelamin
PenyakitKelamin
 
valuation of toxicological implications of inhalationexposure to kerosene fum...
valuation of toxicological implications of inhalationexposure to kerosene fum...valuation of toxicological implications of inhalationexposure to kerosene fum...
valuation of toxicological implications of inhalationexposure to kerosene fum...
 
SPSS GUIDE
SPSS GUIDESPSS GUIDE
SPSS GUIDE
 
865_file_UNEP__20Emergency__20Preparedness_final
865_file_UNEP__20Emergency__20Preparedness_final865_file_UNEP__20Emergency__20Preparedness_final
865_file_UNEP__20Emergency__20Preparedness_final
 
Principles_Of_Hazard_Tree_Risk_Mgmnt
Principles_Of_Hazard_Tree_Risk_MgmntPrinciples_Of_Hazard_Tree_Risk_Mgmnt
Principles_Of_Hazard_Tree_Risk_Mgmnt
 
fire fighting prevention
fire fighting preventionfire fighting prevention
fire fighting prevention
 
PIHAK BERKUASA TEMPATAN
PIHAK BERKUASA TEMPATANPIHAK BERKUASA TEMPATAN
PIHAK BERKUASA TEMPATAN
 
stpfaulttree
stpfaulttreestpfaulttree
stpfaulttree
 
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent VaporGuidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
 
jurnal of occupational safety and health
jurnal of occupational safety and healthjurnal of occupational safety and health
jurnal of occupational safety and health
 
1-introductionbacteria
1-introductionbacteria1-introductionbacteria
1-introductionbacteria
 
Requirement and Technical Standard for Non Convention Cargo
Requirement and Technical Standard for Non Convention Cargo Requirement and Technical Standard for Non Convention Cargo
Requirement and Technical Standard for Non Convention Cargo
 
fault tree analysis
fault tree analysisfault tree analysis
fault tree analysis
 
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
 
japanese encephalitis
japanese encephalitisjapanese encephalitis
japanese encephalitis
 
Communication for behavioral impact(COMBI)
Communication for behavioral impact(COMBI)Communication for behavioral impact(COMBI)
Communication for behavioral impact(COMBI)
 
VECTOR CONTROL
VECTOR CONTROLVECTOR CONTROL
VECTOR CONTROL
 
nominal group technique
nominal group techniquenominal group technique
nominal group technique
 
157-national-medicines-policy-of-malaysia
157-national-medicines-policy-of-malaysia157-national-medicines-policy-of-malaysia
157-national-medicines-policy-of-malaysia
 

Kürzlich hochgeladen

Introduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxIntroduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxJemalSeid25
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfJohnCarloValencia4
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.ukaroemirsr
 
A flour, rice and Suji company in Jhang.
A flour, rice and Suji company in Jhang.A flour, rice and Suji company in Jhang.
A flour, rice and Suji company in Jhang.mcshagufta46
 
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...AustraliaChapterIIBA
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..dlewis191
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsP&CO
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfHajeJanKamps
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyHanna Klim
 
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfAnhNguyen97152
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsIntellect Design Arena Ltd
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursKaiNexus
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhangmcgroupjeya
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...Khaled Al Awadi
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Reportamberjiles31
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsyasinnathani
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZKanakChauhan5
 

Kürzlich hochgeladen (20)

Introduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxIntroduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptx
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.uk
 
A flour, rice and Suji company in Jhang.
A flour, rice and Suji company in Jhang.A flour, rice and Suji company in Jhang.
A flour, rice and Suji company in Jhang.
 
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizations
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdf
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agency
 
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking Applications
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, Ours
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhang
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Report
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story points
 
Investment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV IndustriesInvestment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV Industries
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZ
 

DENGUE FEVER

  • 1. REGIONAL COMMITTEE Provisional Agenda item 10.2 Fifty-fifth Session SEA/RC55/7 11-13 September 2002 25 July 2002 PREVENTION AND CONTROL OF DENGUE, JAPANESE ENCEPHALITIS AND KALA-AZAR IN SEA REGION
  • 3. CONTENTS Page 1. THE SITUATION.................................................................................................................. 1 2. PREVENTION AND CONTROL.......................................................................................... 3 2.1 Regional Strategy for Prevention and Control of DF/DHF ........................................ 3 2.2 Strategy for Prevention and Control of Kala-azar ..................................................... 5 2.3 Strategy for Prevention and Control of Japanese Encephalitis ................................ 6
  • 5. 1. THE SITUATION Dengue fever is an acute febrile viral disease caused by flaviviruses. There are four serotypes 1, 2, 3 and 4. The re-infections of these serotypes are responsible for dengue haemorrhagic fever (DHF) and the virus is transmitted to man by the bite of infective mosquitoes, mainly Aedes aegypti. This disease is now endemic in most of the tropical countries. Dengue fever (DF), with its severe manifestations, such as dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS), has emerged as a major public health problem of international concern. It is a leading cause of childhood mortality in several Asian countries. Fifty two per cent of the population at risk of DF/DHF lives in the WHO South-East Asia Region (Figure 1). The geographical distribution has greatly expanded over the last 30 years because Figure 1. Population at risk of DF/DHF, 2001 Population at risk elsewhere (1.2 billion) 52% 48% Population at risk in SEA Region (1.3 billion) of increased potential for the breeding of Aedes aegypti. Seven countries of the Region (Bangladesh, India, Indonesia, Maldives, Myanmar, Sri Lanka and Thailand) regularly report incidences of DF/DHF every year. Indonesia, Myanmar and Thailand fall in the tropical monsoon and equatorial climatic zone. The annual rainfall received by this region is less than 150 cm. There is widespread distribution of Aedes aegypti mosquito in both urban and rural areas. The transmission period is extended and DHF epidemics occur in 3-5 year cycles, associated with high morbidity in children. Bhutan and Nepal, being high altitude countries, have not reported any case of DF/DHF. DPR Korea, being a country with a temperate climate, has no report of indigenous transmission of DF/DHF. The trend of reported cases of DF/DHF and deaths in the Region for the period 1985- 2000 is shown in Figure 2. The total reported cases ranged from 46 458 in 1986 to 218 859 in 1998. During the epidemic years, the number of cases generally exceeds 100 000. Similarly, reported deaths due to DHF ranged from 2 339 in 1987 to 471 in 1999. The
  • 6. SEA/RC55/7 Page 2 number of deaths due to DHF continues to be high (>1 000) in most of the years. The case- fatality rate, which fluctuated between 2 and 2.5 per cent up to 1990, has shown a downward trend; during 1997-98 it was stable and ranged between 1 and 2 per cent. Following the largest number of cases (218 859) reported in 1998, the number of reported cases declined markedly to 55 405 in 1999 and 57 997 in 2000. The number of deaths declined from 2 075 in 1998 to 471 in 1999 and 542 in 2000. However, the case-fatality rate remained around one per cent in 1999-2000. Kala-azar or visceral leishmaniasis is a chronic and insidious disease caused by an intracellular protozoan (Leishmania species). It is a rural disease and man is the main reservoir of infection. Kala-azar is usually fatal if untreated. Sand fly (Phlebotomus argentipes), the vector of kala-azar, breeds in mud shelters located in peri-domestic and animal shelters. Poverty is a major determinant with the disease affecting the poor population who have little access to health facilities and cannot afford treatment. Over 20% of the world's estimated 0.5 million annual cases occurred in the Indian states of Bihar, West Bengal and Uttar Pradesh. During 1999, a total of 12 728 kala-azar cases (284 deaths) were reported from India, of which 90% cases were detected in Bihar alone. Nepal reported kala-azar in areas along the border with Bihar and West Bengal, with 1 832 cases (28 deaths) in 1999. Bangladesh reported to 5 799 cases (24 deaths) in 1999. Kala-azar has been recognized as a cross-border health problem affecting Bangladesh, India and Nepal. The incidence of kala-azar has a focus in the border districts, particularly on the India-Nepal border. There are sporadic cases in the Bangladesh-India border, but in Bangladesh the problem is more serious in areas far from the border.
  • 7. SEA/RC55/7 Page 3 Figure 2. Number of reported cases of DF/DHF and deaths in the SEA Region* (1985-2001**) 1000000 2.5 Case-fatalityrate (%) No. of cases/deaths 100000 2 10000 1.5 1000 1 100 0.5 10 1 0 2001* 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Cases Deaths Case-fatality rate (%) * Bangladesh, India, Indonesia, Maldives, Myanmar, Sri Lanka and Thailand ** information upto September 2001 Japanese encephalitis (JE) is a mosquito-borne zoonotic disease, caused by a group B arbovirus (flavivirus). It mainly infects animals and birds; Man is an incidental host. The disease usually occurs in areas under rice cultivation or with rich irrigation which favours the breeding of Culex mosquitoes. The risk increases in the presence of a large number of animal reservoir hosts such as pigs. JE is a major public health problem in Asia and is the most important cause of viral encephalitis in the world. The most affected groups are children 1-15 years of age. JE affects rice-producing areas and is characterized by cyclic epidemics every two years. JE is annually reported in four countries of the South-East Asia Region: India, Nepal, Sri Lanka and Thailand. Sporadic cases have also been reported in Indonesia and Myanmar. India and Nepal continue to report a high number of cases and deaths. The total number of cases reported in the Region in 1999 was 6 514 with 1 121 deaths. During the same period, India reported 3 428 cases with 680 deaths, Nepal 2 924 cases (434 deaths) while Sri Lanka and Thailand reported only 102 and 60 cases respectively with 3 and 4 deaths. 2. PREVENTION AND CONTROL 2.1 Regional Strategy for Prevention and Control of DF/DHF
  • 8. SEA/RC55/7 Page 4 The countries of the South-East Asia Region developed a regional strategy for the control of DF/DHF in 1995 which was revised in July 2001 with the following objectives: (1) To establish an effective disease and vector surveillance system based on reliable laboratory and health information systems; (2) To ensure early recognition and effective case management of DHF/DSS to prevent case mortality; (3) To undertake disease prevention and control through integrated vector management with community and intersectoral participation; (4) To undertake activities to achieve sustainable behavioural changes and partnerships; (5) To establish emergency response capacity to control outbreaks with appropriate medical services, vector control, communications and logistics, and (6) To strengthen regional and national capacities to undertake prevention and control of dengue and research related to epidemiology, disease and vector management and behavioural changes. Each country formulated its national control programme according to its priorities, availability of infrastructure, resources, etc. Consequently, Thailand, Indonesia and Myanmar established National Dengue Prevention and Control Programmes while Sri Lanka has established a National Task Force for control of DF/DHF. India, Bangladesh and Maldives do not have National Dengue Control Programmes, but control is integrated as part of vector- borne disease control/malaria control organizations for emergency control of epidemics. Surveillance is crucial for priority setting, policy decision to reduce disease burden, prediction and early detection of epidemics. All the countries of the Region have passive surveillance systems, which do not help in predicting epidemics. Most of the dengue-endemic countries do not have the infrastructure to respond early and effectively to control epidemics. Emphasis is always on fogging and larvicide application. There has been an attempt to mobilize communities to undertake source reduction methods to prevent transmission. In most of the cases, the community will rely almost exclusively on government services to address the problem. Prompt diagnosis and standardized treatment is a key to successful case management and thus reduce the case-fatality rate (CFR). In the SEA Region, clinicians and physicians in Thailand have provided the leadership in this direction. Seminal studies on the pathogenesis and pathophysiological changes in DHF patients were carried out in 1960 at Queen Sirikit’s Institute of Child Health (WHO Collaborating Centre for Clinical Management of DF/DHF), which resulted in the development of guidelines for clinical diagnosis and management of severe cases to bring down CFR below 0.5%. These guidelines were adopted by WHO in 1975 and have also been incorporated into the IMCI (integrated management of childhood illness) protocols of Indonesia, Vietnam and the Philippines. Based on the regional dengue control strategy of “selected, sustainable and integrated control approach with community and intersectoral participation”, the countries of the Region have developed various models of community-based control programme based upon source reduction and have met with varying degree of success.
  • 9. SEA/RC55/7 Page 5 2.2 Strategy for Prevention and Control of Kala-azar Kala-azar control is based on improving access for target population to early case detection and prompt treatment, vector control, health education as well as poverty alleviation measures. Kala-azar diagnosis is costly and unreliable. An antigen-based K-39 test has become available for rapid diagnosis. The anti-leishmaniasis drugs available for treatment are either unresponsive (1st line-SAG) or 2nd line drugs are very expensive (amphotericin B). These drugs are toxic and have to be administered parenterally for long periods. Increasing reports of resistant parasite against these drugs have become a major issue in control efforts. An oral drug, miltefosine, registered in India in early 2002, is under consideration for control programme in the India- Nepal border districts. Low coverage and periodic interruptions frequently hamper the vector control approach based on residual insecticide house spraying. Experience in the past has shown that the incidence of kala-azar could be kept at a very low level for several years following large-scale interventions; the disease re-emerged when interventions could not be sustained. Thus, from the economic point of view, eradication of visceral leishmaniasis is not feasible, while control strategy would be too slow to contain the spread of the disease. Kala-azar elimination Objective Progressive reduction of human reservoir until the disease is no longer a public health problem. Target By 2012, the annual incidence of kala-azar at the village level will not exceed 1 per 1 000 population. Time-frame 2003-2012 Strategy • Early detection: Community awareness of the symptoms of kala-azar and when to seek treatment; surveillance and monitoring of drug resistance. Scaling up intervention targeting villages with a high burden of disease. Identification of individual cases using dipsticks followed by treatment with oral miltefosine. Use DOTS method to ensure compliance. • Prompt treatment in the nearest health facility: Common protocol for diagnosis by using dipsticks, whenever possible, followed by treatment with oral miltefosine; community awareness on where to seek treatment and compliance. • Multi-disease approach and multi-pronged interventions: Integrated care with other disease control such as malaria; promote wide use of insecticide-treated nets for community protection; environmental sanitation in and around the house; and integrated vector control. Application of two rounds of spraying with DDT for three consecutive years to quickly reduce vector density and curtail disease transmission.
  • 10. SEA/RC55/7 Page 6 • Structured technical support: Institutional support for technical networks for capacity building, Kala-azar cell in NAMP. • Operations research: Establishment of indicators for monitoring progress of elimination; behavioural study for promotion of community action. • Coalition of stakeholders: Government, civil society, private sector, international organizations, research institutions and foundations. Implementation • Programme will be implemented as part of cross-border collaboration under ICP- II 2002-2003 in four pilot districts, i.e. one each on the India-Nepal border and, similarly, one each on the Bangladesh-India border. • Partnerships with industries to ensure the availability of cheap, reliable and sustainable supply of drugs, dipstick tests and insecticide for indoor residual spray. • Development of a sensitive dipstick method for early detection of kala-azar. • Production and marketing of affordable oral miltefosine as a drug of choice. • Development of kala-azar vaccine, drug and diagnostic tools. 2.3 Strategy for Prevention and Control of Japanese Encephalitis The strategy for prevention and control of JE includes three components: (1) Health education and training; (2) Vector control; (3) Immunization, and (4) Epidemic preparedness and response. Health Education • Simple Information on JE - cause, transmission and prevention of mosquito bites. • Community action in reducing mosquito breeding places by filling pools, weekly drainage of accumulated water, lowering of water levels in rice fields etc. • National guidelines for diagnosis, management and prevention of JE - for programme managers and health professionals. Vector Control Insecticide spraying is not considered as a major strategy. However, for the immediate suppression of infective vectors, ULV or thermal fogging may be employed, which again is not very cost-effective. Environmental measures are recommended. Short-term measures • Larviciding - impractical for widespread breeding habitats. Long-term measures
  • 11. SEA/RC55/7 Page 7 • Water management, specially in irrigated rice fields, e.g. periodic drying of fields. • Selection of rice varieties with minimum water requirements. • Use of larvivorous fish. • Environment manipulations like reduction of drainage, filling and weeding. Immunization • of population at risk i.e. children • of pigs Vaccination of humans is the only realistic tool to control JE. WHO recommends the use of JE vaccine wherever it is affordable. Suggestions have been made to incorporate the vaccine into EPI programmes in Asia. Immunization of children Since JE is annually reported in a few districts or pockets in the four JE endemic countries, e.g. on either side of the border between Nepal and India, immunization of children aged 6 months to 12 years is feasible. There are at least three vaccines being used: inactivated virus grown in mouse brain, inactivated virus grown on primary hamster kidney cells and live attenuated virus grown in primary hamster kidney cells (SA-14-14-2). Vaccines have been used in Japan, Republic of Korea, Taiwan, China, Thailand and Nepal. A pilot study in Nepal found an eight-fold reduction compared with previous years and up to 88% of JE cases detected were found among unvaccinated people. China and Japan have successfully implemented vaccination with impressive results. Pig vaccination This is very costly, difficult and time-consuming. Pigs are normally slaughtered at 6-8 months of age. Vaccination must begin when maternal antibodies have decreased but before the pig becomes viraemic. Pig control has also been tried through segregation or slaughtering but this is difficult and the economic losses are high. Therefore, human vaccination is the most feasible and cost-effective tool for JE control. Epidemic Preparedness and Response (1) Immediately notify government authorities by phone, fax or email. (2) A team of investigators consisting of clinicians, epidemiologists, entomologists etc. should be immediately sent to the affected site. (3) The team should be provided proper information on collection of specimens : – stool samples – for isolation of enterovirus – blood or serum on the first three days of the illness – for detection or isolation of virus – paired serum samples at an interval of at least 10 days – for antibody detection
  • 12. SEA/RC55/7 Page 8 – CSF – for virus isolation and antibody tests – in case of deaths – tissue samples of brain and liver. All samples must be stored in a cool place. For virus isolation, samples must be stored at temperatures below –20oC.